(Q77292784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

J C Stringham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

D A Bull

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

T C Fuller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A G Kfoury

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

D O Taylor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

D G Renlund

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S V Karwande

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Heart and Lung Transplantation

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

160-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

Factors influencing HLA sensitization in implantable LVAD recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

"Hyperacute" renal-homograft rejection in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

New approaches to donor crossmatching and successful transplantation of highly sensitized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

Utilization of intravenous immunoglobulin to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation. Fluorescence-activated cell sorter analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

Plasmapheresis followed by intravenous immunoglobulin in presensitized patients awaiting thoracic organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2898%2900006-0

7 January 2021

10.1016/S1053-2498(98)00006-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194040%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference